United Therapeutics (UTHR) Misses Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $510.38 --0%
Revenue Growth %: -1.2%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: -1.2%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $6.39, $0.14 worse than the analyst estimate of $6.53. Revenue for the quarter came in at $748.9 million versus the consensus estimate of $722.95 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- William Blair Issues Conviction List for September
- Aon Corp (AON) PT Lowered to $433 at Cantor Fitzgerald on Disappointing Upside from Deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
